SBRA Q3 FY26 earnings call: key takeaways

• SBRA reported normalized FFO per share of $0.39, matching the consensus estimate of $0.39 (6:51)
• The company raised its 2026 earnings guidance, projecting 7% year-over-year growth in normalized FFO and 8% in normalized AFFO. (8:29)

Results vs expectations

EPS basis: Unverified: provider EPS matches neither the SEC filing nor the press release

The stock moved +3.2% over the report window (S&P 500 ETF +0.3%). Earnings history

What changed since last quarter

• The company raised its 2026 earnings guidance for normalized FFO and AFFO, citing stronger performance in the shop portfolio. (8:29)
• SBRA expects to transition to a 50% shop exposure by the end of 2027, highlighting the growth in its senior housing portfolio. (2:06)
• The company mentioned that the majority of its pipeline consists of off-market deals, indicating a strategic shift in acquisition approach. (35:34)

What analysts pressed on

• Whether the company will see pricing power as occupancy approaches 90%. (42:46)
• Concerns about the impact of potential Medicaid policy changes on the skilled nursing and senior housing sectors. (29:58)
• Questions about the company's approach to capital allocation and the use of leverage for future investments. (33:48)

In their words

• Our same-store shop cash NOI margins at 34.9%, which is best in class. Sabra Healthcare REIT (2:06)
• We see no barriers that would prevent this momentum from continuing. Sabra Healthcare REIT (2:06)
• Our focus on optimizing rents was evident in our July announcement... Sabra Healthcare REIT (2:06)
• We'll see you next time. The strategic focus that we've had will result in 7% to 8% year-over-year earnings growth at the midpoint of guidance this year. (3:29)